As a pharmacist with a fervent enthusiasm for formulation, Paromita is currently a PhD candidate at McGill University. Engaged in research at the intersection of pharmaceutics and medical devices, she is immersed in a dynamic field that involves developing innovative tools and treatments with direct implications for patient care. Her doctoral studies provide ample opportunities for exploration and collaboration, particularly in the realm of medical device research. Investigating the intricacies of drug delivery systems and the interaction of formulations with the human body, she is dedicated to pioneering new approaches that enhance medication administration and improve patient outcomes. With her unique blend of pharmacy expertise and a passion for formulation science, she plays a pivotal role in bridging pharmaceuticals and medical devices, ensuring that the therapies she contributes to are not only efficacious but also safe and user-friendly.
A baculoviral gene and drug-eluting (GDES) stent to promote re-endothelialization and prevent restenosis caused by atherosclerosis.
Event: ESC Congress 2024
Topic: Revascularisation
Session: Integrating insights: from biomarkers to therapeutics in the management of acute coronary syndromes
